Arrowhead Pharmaceuticals US04280A1007

GRTS (mRNA) Gritstone bio inc.

1. Ron Kerstens 18 oktober 2024 11:19

   auteur info

   • Ron Kerstens

     Lid sinds: 16 dec 2011

     Laatste bezoek: 04 jan 2025

   • Aanbevelingen

     Ontvangen: 4298

     Gegeven: 718

   •    Aantal posts: 5.558

   Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
   
   Trading of the Company’s common stock will be suspended at the opening of business on October 22, 2024 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq.